Evidence map›Paper›PMID 37056252›Full record

ReviewBioactive materials2023

Bone/cartilage organoid on-chip: Construction strategy and application.

Yan Hu, Hao Zhang, Sicheng Wang, Liehu Cao, Fengjin Zhou, Yingying Jing, Jiacan Su

Abstract readReview
In one paragraph

Review in Bioactive materials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Artificial intelligence virtual bone organoids (AIVBOs).Journal of orthopaedic translation · 2026
    Review
  6. Bone organoids and mitochondrial reprogramming.Journal of orthopaedic translation · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Bone Organoids: A Novel Tool for Modeling and Managing Skeletal Disorders in Diabetes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yan HuInstitute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
Hao ZhangInstitute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
Sicheng WangDepartment of Orthopaedics, Shanghai Zhongye Hospital, Shanghai, 201941, China.
Liehu CaoDepartment of Orthopaedics, Shanghai Baoshan Luodian Hospital, Shanghai, 201908, China.
Fengjin ZhouDepartment of Orthopaedics, Honghui Hospital, Xi'an Jiao Tong University, Xi'an, 710000, China.
Yingying JingInstitute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
Jiacan SuInstitute of Translational Medicine, Shanghai University, Shanghai, 200444, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The necessity of disease models for bone/cartilage related disorders is well-recognized, but the barrier between

Indexed as

Ex-vivo disease modelOn-chip platformOrganoidOsteochondral unit

Identifiers

PMID37056252
PMCPMC10087111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.